Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-06 Rodriguez Susan Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +195,000 195,000
2021-11-22 Rodriguez Susan Chief Commercial Officer Sale −643 $0.99 $638 197,030
2021-10-08 Rodriguez Susan Chief Commercial Officer Grant or award +150,000 197,673
2021-08-20 Rodriguez Susan Chief Commercial Officer Sale −630 $1.32 $832 44,673
2021-05-20 Rodriguez Susan Chief Commercial Officer Sale −611 $7.09 $4K 45,303
2021-02-22 Rodriguez Susan Chief Commercial Officer Sale −611 $6.88 $4K 45,914
2021-01-05 Rodriguez Susan Chief Commercial Officer Grant or award +32,612 46,525
2021-01-05 Rodriguez Susan Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +146,755 146,755
2020-09-16 Rodriguez Susan Chief Commercial Officer Sale −6,087 $6.11 $37K 13,913
2020-05-18 Rodriguez Susan Chief Commercial Officer Grant or award +20,000 20,000
2020-05-18 Rodriguez Susan Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +232,750 232,750

Page 2 of 2 · 31 trades